27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Autolus Therapeutics (NASDAQ:AUTL) shares are trading higher on Monday after the company announced the publication of its new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine.
Autolus Therapeutics PLC is a biopharmaceutical company. It's engaged in the development of next-generation programmed T cell therapies for the treatment of cancer.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Autolus Therapeutics shares were trading up 6.70% at $10.25 at the time of publication on Monday. The stock has a 52-week high of $17.19 and a 52-week low of $3.
Cerus (NASDAQ:CERS) shares were trading higher after the company announced that the FDA approved its INTERCEPT blood system for cryoprecipitation.
Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites.
Cerus shares traded higher but were down 0.46% at $6.55 at the time of publication on Monday. The stock has a 52-week high of $7.94 and a 52-week low of $2.71.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.